Principles underlying the use of Holter monitoring to define the efficacy of antiarrhythmic drugs.
Moss
A J
AJ
Department of Preventive and Community Medicine, University of Rochester Medical Center, NY 14642.
Zareba
W
W
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D002311:Cardiomyopathy, Dilated / Q000150:complications; D003327:Coronary Disease / Q000150:complications; D015716:Electrocardiography, Ambulatory; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D017180:Tachycardia, Ventricular / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents